EDRS
HZNP

Edmond de Rothschild (Suisse)’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Edmond de Rothschild (Suisse)’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-3,635
Closed -$60K – 492
2016
Q2 		$60K Buy
+3,635
New +$58.8K 0.02% 262

Other funds holding HZNP

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Edmond de Rothschild (Suisse)'s HZNP Position: Q3 2016 in Review

Edmond de Rothschild (Suisse) sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q3 2016, closing a stake of 3,635 shares — an estimated $60K sold.

Edmond de Rothschild (Suisse) first reported a position in HZNP in Q2 2016 and held it in 1 quarter. The position peaked at $60K in Q2 2016. 233 funds tracked by Wall St. Rank hold HZNP as of Q3 2016.

  • Edmond de Rothschild (Suisse) reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q3 2016 after selling out during the quarter.
  • Edmond de Rothschild (Suisse) sold 3,635 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q3 2016, an estimated $60K.
  • Edmond de Rothschild (Suisse) first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2016 and held it in 1 quarter.
  • Edmond de Rothschild (Suisse)'s Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $60K in Q2 2016.
  • 233 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q3 2016.

Based on Edmond de Rothschild (Suisse)'s 13F filing for Q3 2016, filed 14 Nov 2016.